Interestingly, analysis of EVs from 4T1 tumor-bearing mice demonstrated that the reserpine treatment resulted in EVs with less flotillin-1 (FLOT-1) and GAPDH bands of larger or smaller size compared to the other treatment conditions [Supplementary Figure 2B]. This evidence concerns the gene FLOT1 and neoplasm.